{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:41:54Z","timestamp":1773268914366,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1373\/clinchem.2005.060178","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T04:13:13Z","timestamp":1141186393000},"page":"539-540","source":"Crossref","is-referenced-by-count":2,"title":["Multiplex Protocol Suitable for Screening for MECP2 Mutations in Girls with Mental Retardation"],"prefix":"10.1093","volume":"52","author":[{"given":"Cla\u0301udia MB","family":"Carvalho","sequence":"first","affiliation":[{"name":"Departamento de Bioqui\u0301mica, e Imunologia, Universidade Federal, de Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Camargos","sequence":"first","affiliation":[{"name":"Psiquiatra Infantil do, Centro Geral de Pediatria, Fundacao Hospitalar de Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se\u0301rgio DJ","family":"Pena","sequence":"first","affiliation":[{"name":"Departamento de Bioqui\u0301mica, e Imunologia, Universidade Federal, de Minas Gerais, Belo Horizonte, MG, Brazil"},{"name":"GENE-Nu\u0301cleo de Genetica, Medica de Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2020022801221847400_R1","doi-asserted-by":"crossref","unstructured":"Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet1999;23:185-188.","DOI":"10.1038\/13810"},{"key":"2020022801221847400_R2","doi-asserted-by":"crossref","unstructured":"Orrico A, Lam C, Galli L, Dotti MT, Hayek G, Tong SF, et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett2000;481:285-288.","DOI":"10.1016\/S0014-5793(00)01994-3"},{"key":"2020022801221847400_R3","doi-asserted-by":"crossref","unstructured":"Couvert P, Bienvenu T, Aquaviva C, Poirier K, Moraine C, Gendrot C, et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet2001;10:941-946.","DOI":"10.1093\/hmg\/10.9.941"},{"key":"2020022801221847400_R4","doi-asserted-by":"crossref","unstructured":"Imessaoudene B, Bonnefont JP, Royer G, Cormier-Daire V, Lyonnet S, Lyon G, et al. MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet2001;38:171-174.","DOI":"10.1136\/jmg.38.3.171"},{"key":"2020022801221847400_R5","doi-asserted-by":"crossref","unstructured":"Watson P, Black G, Ramsden S, Barrow M, Super M, Kerr B, et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet2001;38:224-228.","DOI":"10.1136\/jmg.38.4.224"},{"key":"2020022801221847400_R6","doi-asserted-by":"crossref","unstructured":"Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A. Mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-syndrome. Am J Hum Genet2002;70:1034-1037.","DOI":"10.1086\/339553"},{"key":"2020022801221847400_R7","doi-asserted-by":"crossref","unstructured":"Kleefstra T, Yntema HG, Oudakker AR, Romein T, Sistermans E, Nillessen W, et al. De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Clin Genet2002;61:359-362.","DOI":"10.1034\/j.1399-0004.2002.610507.x"},{"key":"2020022801221847400_R8","doi-asserted-by":"crossref","unstructured":"Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet2002;11:115-124.","DOI":"10.1093\/hmg\/11.2.115"},{"key":"2020022801221847400_R9","doi-asserted-by":"crossref","unstructured":"Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science2003;302:885-889.","DOI":"10.1126\/science.1086446"},{"key":"2020022801221847400_R10","doi-asserted-by":"crossref","unstructured":"Samaco RC, Hogart A, LaSalle JM. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet2005;14:483-492.","DOI":"10.1093\/hmg\/ddi045"},{"key":"2020022801221847400_R11","doi-asserted-by":"crossref","unstructured":"Villard L, Kpebe A, Cardoso C, Chelly PJ, Tardieu PM, Fontes M. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology2000;55:1188-1193.","DOI":"10.1212\/WNL.55.8.1188"},{"key":"2020022801221847400_R12","doi-asserted-by":"crossref","unstructured":"Miltenberger-Miltenyi G, Laccone F. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum Mutat2003;22:107-115.","DOI":"10.1002\/humu.10243"},{"key":"2020022801221847400_R13","doi-asserted-by":"crossref","unstructured":"Schanen C, Houwink EJ, Dorrani N, Lane J, Everett R, Feng A, et al. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet A2004;126:129-140.","DOI":"10.1002\/ajmg.a.20571"},{"key":"2020022801221847400_R14","doi-asserted-by":"crossref","unstructured":"Webb T, Latif F. Rett syndrome and the MECP2 gene. J Med Genet2001;38:217-223.","DOI":"10.1136\/jmg.38.4.217"},{"key":"2020022801221847400_R15","doi-asserted-by":"crossref","unstructured":"Fukuda T, Yamashita Y, Nagamitsu S, Miyamoto K, Jin JJ, Ohmori I, et al. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms. Brain Dev2005;27:211-217.","DOI":"10.1016\/j.braindev.2004.06.003"},{"key":"2020022801221847400_R16","doi-asserted-by":"crossref","unstructured":"Kleefstra T, Yntema HG, Nillesen WM, Oudakker AR, Mullaart RA, Geerdink N, et al. MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur J Hum Genet2004;12:24-28.","DOI":"10.1038\/sj.ejhg.5201080"},{"key":"2020022801221847400_R17","unstructured":". International Rett Syndrome Association. RettBase: IRSA MECP2 Variation Databasehttp:\/\/mecp2.chw.edu.au (accessed July 2005)."},{"key":"2020022801221847400_R18","unstructured":"Carvalho CMB, Pena SDJ. Optimization of a multiplex minisequencing protocol for population studies and medical genetics. Genet Mol Res2005;4:115-125."},{"key":"2020022801221847400_R19","unstructured":". Coriell Institute for Medical Research. Coriell Cell Repositorieshttp:\/\/locus.umdnj.edu\/ccr\/ (accessed July 2005)."},{"key":"2020022801221847400_R20","doi-asserted-by":"crossref","unstructured":"Lossie AC, Whitney MM, Amidon D, Dong HJ, Chen P, Theriaque D, et al. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet2001;38:834-845.","DOI":"10.1136\/jmg.38.12.834"},{"key":"2020022801221847400_R21","doi-asserted-by":"crossref","unstructured":"Shahbazian MD, Zoghbi HY. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr Opin Neurol2001;14:171-176.","DOI":"10.1097\/00019052-200104000-00006"},{"key":"2020022801221847400_R22","doi-asserted-by":"crossref","unstructured":"Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology2003;60:367-380.","DOI":"10.1212\/01.WNL.0000031431.81555.16"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/3\/539\/32686712\/clinchem0539.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/3\/539\/32686712\/clinchem0539.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T06:22:41Z","timestamp":1582870961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/52\/3\/539\/5626683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2005.060178","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,3,1]]},"published":{"date-parts":[[2006,3,1]]}}}